"What broadening?" says Goldman Sachs head of custom equity baskets, Louis Miller, to start his latest 'Global Reflections' note.

Some market participants thought an MOU on Iran would lead to a potentially ‘Pfizer vaccine’ style rotation, and this unequivocally has not happened, and doesn’t appear imminent absent an exogenous shock.

The trade is still long AI.